Page last updated: 2024-08-23

etoposide and anisomycin

etoposide has been researched along with anisomycin in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's7 (63.64)29.6817
2010's2 (18.18)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Choi, EJ; Han, PL; Kim, I; Lee, K; Oh, YJ; Park, J1
Bouchard, D; del Barco Barrantes, I; Duncan, GS; Elia, A; Mak, TW; Millar, DG; Nguyen, L; Ohashi, PS; Plyte, S; Ruland, J; Wakeham, A1
Augery-Bourget, Y; Poindessous-Jazat, V; Robert-Lézénès, J1
Maag, RS; Machamer, CE; Mancini, M; Rosen, A1
Chang, NS; Doherty, J; Ensign, A; Hong, Q; Hsu, LJ; Schultz, L1
Abayasiriwardana, KS; Barbone, D; Broaddus, VC; Dansen, TB; Evan, GI; Hunt, AE; Kim, KU; Lee, KK; Vivo, C1
Koike, A; Koike, M; Ninomiya, Y1
Lee, SW; Liou, YC; Ongusaha, P; Xia, Y1
Cao, J; Cao, M; Du, L; Feng, J; Jin, J; Li, X; Liang, S; Shen, B; Wang, H; Wang, J; Yu, J; Zhang, J; Zhang, Y; Zhou, Y; Zhu, T1

Other Studies

11 other study(ies) available for etoposide and anisomycin

ArticleYear
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:11

    Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2.
    The Journal of biological chemistry, 1997, Jul-04, Volume: 272, Issue:27

    Topics: Animals; Anisomycin; Antineoplastic Agents, Phytogenic; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Carcinogens; DNA Fragmentation; Enzyme Activation; Etoposide; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Transfection; Tumor Cells, Cultured; Ultraviolet Rays

1997
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.
    Cell, 2001, Jan-12, Volume: 104, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Animals; Anisomycin; Antibody Formation; Antineoplastic Agents; Apoptosis; B-Cell CLL-Lymphoma 10 Protein; B-Lymphocytes; Cell Division; Central Nervous System; Cisplatin; Enzyme Inhibitors; Etoposide; Genes, Lethal; Immunity, Cellular; Lymphocyte Activation; Mice; Mice, Knockout; Neoplasm Proteins; Neural Tube Defects; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Receptors, Antigen; Signal Transduction; Staurosporine; T-Lymphocytes

2001
C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells.
    Leukemia, 2002, Volume: 16, Issue:2

    Topics: Animals; Anisomycin; Antibiotics, Antineoplastic; Apoptosis; Cell Differentiation; Culture Media, Serum-Free; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; Dimethyl Sulfoxide; DNA, Antisense; Enzyme Activation; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Leukemic; Genes, jun; JNK Mitogen-Activated Protein Kinases; Leukemia, Erythroblastic, Acute; Mice; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-jun; Recombinant Fusion Proteins; Topoisomerase II Inhibitors; Transfection; Tumor Cells, Cultured

2002
Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors.
    Molecular biology of the cell, 2005, Volume: 16, Issue:6

    Topics: Anisomycin; Apoptosis; Apoptosis Regulatory Proteins; Autoantigens; Caspases; Enzyme Inhibitors; Etoposide; Fluorescent Antibody Technique, Indirect; Golgi Matrix Proteins; Green Fluorescent Proteins; HeLa Cells; Humans; Kinetics; Membrane Glycoproteins; Membrane Proteins; Microscopy, Fluorescence; Mutation; Nucleic Acid Synthesis Inhibitors; Precipitin Tests; Staurosporine; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2005
WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.
    The Journal of biological chemistry, 2005, Dec-30, Volume: 280, Issue:52

    Topics: Active Transport, Cell Nucleus; Animals; Anisomycin; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Cytosol; DNA, Complementary; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Genes, Dominant; Humans; Hypoxia; Imidazoles; Immunoprecipitation; Luminescent Proteins; Mice; Microscopy, Fluorescence; Models, Biological; Oxidoreductases; Phosphorylation; Piperazines; Proteasome Endopeptidase Complex; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine; Staurosporine; Time Factors; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Two-Hybrid System Techniques; Tyrosine; U937 Cells; Ultraviolet Rays; WW Domain-Containing Oxidoreductase

2005
Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:10

    Topics: Anisomycin; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Combined Modality Therapy; Cycloheximide; Drug Synergism; Electrophoresis, Gel, Two-Dimensional; Etoposide; Humans; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Ligands; Membrane Proteins; Mesothelioma; Phosphorylation; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured

2007
Characterization of Ninjurin and TSC22 induction after X-irradiation of normal human skin cells.
    The Journal of dermatology, 2008, Volume: 35, Issue:1

    Topics: Anisomycin; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Northern; Cell Adhesion Molecules, Neuronal; Cell Cycle Proteins; Cell Line; Dose-Response Relationship, Radiation; Etoposide; Gene Expression Profiling; Gene Expression Regulation; Humans; Keratinocytes; Nerve Growth Factors; Oligonucleotide Array Sequence Analysis; Plasmids; Repressor Proteins; RNA, Messenger; Transfection

2008
Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.
    The Journal of biological chemistry, 2009, Jun-26, Volume: 284, Issue:26

    Topics: Animals; Anisomycin; Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; DNA Damage; Embryo, Mammalian; Enzyme Inhibitors; Etoposide; Fas Ligand Protein; Fibroblasts; Hydrogen Peroxide; Immunoblotting; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Nucleic Acid Synthesis Inhibitors; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 2C; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Staurosporine; Tumor Suppressor Protein p53; Ultraviolet Rays

2009
Components of the JNK-MAPK pathway play distinct roles in hepatocellular carcinoma.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:19

    Topics: Anisomycin; Apoptosis; Carcinoma, Hepatocellular; Etoposide; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 7; Tumor Necrosis Factor-alpha

2023